Literature DB >> 2544306

Determination of subcutaneous tumor size in athymic (nude) mice.

M M Tomayko1, C P Reynolds.   

Abstract

The athymic (nude) mouse is a useful model for studying the biology and response to therapies of human tumors in vivo. A survey of recent literature revealed the use of 19 different formulas for determining the size of subcutaneous tumors grown as xenografts in nude mice (2 for determining tumor area, 3 for tumor diameter, and 14 for calculating tumor volume). We compared the volumes, areas, and diameters predicted by each of the 19 formulas with the actual weights of 50 tumors ranging from 0.46 to 22.0 g established in nude mice as xenografts from human cell lines. In addition to determining how well each formula predicted relative tumor size, we analyzed how well each formula estimated actual tumor mass. The ellipsoid volume formulas (pi/6 x L x W x H and 1/2 x L x W x H) were best for estimating tumor mass (r = 0.93), whereas measurements of diameter correlated poorly with tumor mass (r less than 0.66). Although determination of tumor area correlated well with tumor mass in small tumors (r = 0.89), correlations of area with tumor mass for large tumors were poor (r = 0.41). We conclude that determination of the ellipsoid volume from measurements of three axes consistently yields the most accurate estimations of both relative and actual tumor mass.

Entities:  

Mesh:

Year:  1989        PMID: 2544306     DOI: 10.1007/BF00300234

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  65 in total

1.  FUNCTION OF THE THYMUS AND GROWTH OF TUMOUR HOMOGRAFT.

Authors:  G C PERRI; M FAULK; E SHAPIRO; J MELLORS; W L MONEY
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

2.  Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice.

Authors:  N K Cheung; B Landmeier; J Neely; A D Nelson; C Abramowsky; S Ellery; R B Adams; F Miraldi
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

3.  Response to ionizing radiation of human bladder transitional cell carcinomas grown in the nude mouse.

Authors:  A P Kyriazis; A Yagoda; A A Kyriazis; J G Kereiakes; W B McCombs
Journal:  Exp Cell Biol       Date:  1985

4.  Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice.

Authors:  J B Santon; M T Cronin; C L MacLeod; J Mendelsohn; H Masui; G N Gill
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

5.  Transfer of age-associated restrained tumor growth in mice by old-to-young bone marrow transplantation.

Authors:  W B Ershler; A L Moore; H Shore; R L Gamelli
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

6.  Selection and adaptation for rapid growth in culture of cells from delayed sarcomas in nude mice.

Authors:  H Rubin; B M Chu; P Arnstein
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

7.  Chemotherapy of human tumor xenografts in genetically athymic mice.

Authors:  A A Ovejera; D P Houchens; A D Barker
Journal:  Ann Clin Lab Sci       Date:  1978 Jan-Feb       Impact factor: 1.256

8.  Bladder cancer xenografts: a model of tumor cell heterogeneity.

Authors:  P J Russell; D Raghavan; P Gregory; J Philips; E J Wills; M Jelbart; J Wass; R A Zbroja; P C Vincent
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

9.  Phenotypic instability of mouse melanomas after propagation in vivo and in vitro.

Authors:  J Berkelhammer; T N Luethans; R R Hook; R W Oxenhandler
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

10.  Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice.

Authors:  N Brünner; M Spang-Thomsen; L Vindeløv; J Wolff; S A Engelholm
Journal:  Eur J Cancer Clin Oncol       Date:  1985-11
View more
  647 in total

1.  Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance.

Authors:  Katherine J O'Malley; Gabrielle Langmann; Junkui Ai; Raquel Ramos-Garcia; Robert L Vessella; Zhou Wang
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

2.  Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.

Authors:  Yue Wu; Li Tang; Gissou Azabdaftari; Elena Pop; Gary J Smith
Journal:  Mol Cell Endocrinol       Date:  2019-02-23       Impact factor: 4.102

3.  Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.

Authors:  Hua Fang; Theresa M Harned; Ondrej Kalous; Vanessa Maldonado; Yves A DeClerck; C Patrick Reynolds
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

4.  Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

Authors:  Lin Zhang; Nuo Yang; Jose-Ramon Conejo Garcia; Alisha Mohamed; Fabian Benencia; Stephen C Rubin; David Allman; George Coukos
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

5.  Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPET.

Authors:  Iljung Lee; Kwang Yup Yoon; Choong Mo Kang; Xin Lin; Xiaoyuan Chen; Jung Young Kim; Sung-Min Kim; Eun Kyoung Ryu; Yearn Seong Choe
Journal:  Nucl Med Biol       Date:  2012-03-09       Impact factor: 2.408

6.  Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling.

Authors:  Vincent Crenn; Kevin Biteau; Jérôme Amiaud; Clotilde Dumars; Romain Guiho; Luciano Vidal; Louis-Romée Le Nail; Dominique Heymann; Anne Moreau; François Gouin; Françoise Redini
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

7.  CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ.

Authors:  Frederick Allen; Iuliana D Bobanga; Peter Rauhe; Deborah Barkauskas; Nathan Teich; Caryn Tong; Jay Myers; Alex Y Huang
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

8.  A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.

Authors:  H M Horton; D Anderson; P Hernandez; K M Barnhart; J A Norman; S E Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines.

Authors:  Chie Ishikawa; Masachika Senba; Naoki Mori
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

10.  Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment.

Authors:  Ayman J Oweida; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Natalie Serkova; Sana D Karam
Journal:  J Vis Exp       Date:  2019-04-22       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.